BDNF affects the mediating effect of negative symptoms on the relationship between age of onset and cognition in patients with chronic schizophrenia
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
BDNF affects the mediating effect of negative symptoms on the relationship between age of onset and cognition in patients with chronic schizophrenia
Authors
Keywords
Age of onset, Negative symptoms, Cognitive function, BDNF, Schizophrenia
Journal
PSYCHONEUROENDOCRINOLOGY
Volume 125, Issue -, Pages 105121
Publisher
Elsevier BV
Online
2020-12-27
DOI
10.1016/j.psyneuen.2020.105121
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Negative and disorganized symptoms mediate the relationship between verbal learning and global functioning in adolescents with early-onset psychosis
- (2020) Runar Elle Smelror et al. EUROPEAN CHILD & ADOLESCENT PSYCHIATRY
- Neurobiology of BDNF in fear memory, sensitivity to stress, and stress-related disorders
- (2020) Michael Notaras et al. MOLECULAR PSYCHIATRY
- Deep Transcranial Magnetic Stimulation for the Treatment of Negative Symptoms in Schizophrenia
- (2019) Sergio Linsambarth et al. JOURNAL OF ECT
- The schizophrenia genetics knowledgebase: a comprehensive update of findings from candidate gene studies
- (2019) Chenxing Liu et al. Translational Psychiatry
- At Issue: Are Negative Symptoms Merely the “Real World” Consequences of Deficits in Social Cognition?
- (2019) Andrea Pelletier-Baldelli et al. SCHIZOPHRENIA BULLETIN
- PRONOUNCED HYPERACTIVITY, COGNITIVE DYSFUNCTIONS AND BDNF DYSREGULATION IN DOPAMINE TRANSPORTER KNOCKOUT RATS
- (2018) Damiana Leo et al. JOURNAL OF NEUROSCIENCE
- Cognitive impairments and low BDNF serum levels in first-episode drug-naive patients with schizophrenia
- (2018) Lijuan Man et al. PSYCHIATRY RESEARCH
- The relationship between negative symptoms and cognitive functioning in patients at clinical high risk for psychosis
- (2018) Letizia Leanza et al. PSYCHIATRY RESEARCH
- Effects of 12-month, double-blind N-acetyl cysteine on symptoms, cognition and brain morphology in early phase schizophrenia spectrum disorders
- (2018) Alan Breier et al. SCHIZOPHRENIA RESEARCH
- Actions of Brain-Derived Neurotrophin Factor in the Neurogenesis and Neuronal Function, and Its Involvement in the Pathophysiology of Brain Diseases
- (2018) Tadahiro Numakawa et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Brain-Derived Neurotrophic Factor (BDNF): Novel Insights into Regulation and Genetic Variation
- (2018) Michael Notaras et al. NEUROSCIENTIST
- Negative symptoms: History of the concept and their position in diagnosis of schizophrenia
- (2017) Sonia Dollfus et al. SCHIZOPHRENIA RESEARCH
- The BDNF Val66Met polymorphism regulates glucocorticoid-induced corticohippocampal remodeling and behavioral despair
- (2017) M Notaras et al. Translational Psychiatry
- BDNF polymorphisms are associated with schizophrenia onset and positive symptoms
- (2016) Xiang Yang Zhang et al. SCHIZOPHRENIA RESEARCH
- Brain-Derived Neurotrophic Factor Gene Val66Met Polymorphism and Risk of Schizophrenia: A Meta-analysis of Case–Control Studies
- (2015) Majid Kheirollahi et al. CELLULAR AND MOLECULAR NEUROBIOLOGY
- Lower Brain-Derived Neurotropic Factor Levels in Untreated Adolescents With First-Episode Psychosis
- (2015) Şeref Şimşek et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- A role for the BDNF gene Val66Met polymorphism in schizophrenia? A comprehensive review
- (2015) Michael Notaras et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Age or age at onset? Which of them really matters for neuro and social cognition in schizophrenia?
- (2015) Magdalena Linke et al. PSYCHIATRY RESEARCH
- Treatments of Negative Symptoms in Schizophrenia: Meta-Analysis of 168 Randomized Placebo-Controlled Trials
- (2014) Paolo Fusar-Poli et al. SCHIZOPHRENIA BULLETIN
- BDNF val66met Polymorphism Is Associated With Age at Onset and Intensity of Symptoms of Paranoid Schizophrenia in a Polish Population
- (2013) Renata Suchanek et al. JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES
- Clinical symptoms, mainly negative symptoms, mediate the influence of neurocognition and social cognition on functional outcome of schizophrenia
- (2013) Chieh-Hsin Lin et al. SCHIZOPHRENIA RESEARCH
- Cognitive and serum BDNF correlates of BDNF Val66Met gene polymorphism in patients with schizophrenia and normal controls
- (2012) Xiang Yang Zhang et al. HUMAN GENETICS
- Abnormal Functional Activation and Connectivity in the Working Memory Network in Early-Onset Schizophrenia
- (2012) Marinos Kyriakopoulos et al. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
- Increase in Serum Brain-Derived Neurotrophic Factor in Met Allele Carriers of the BDNF Val66Met Polymorphism Is Specific to Males
- (2012) Boudewijn A.A. Bus et al. NEUROPSYCHOBIOLOGY
- Lack of effect of brain derived neurotrophic factor (BDNF) Val66Met polymorphism on early onset schizophrenia in Chinese Han population
- (2011) Zhenghui Yi et al. BRAIN RESEARCH
- Association of serum BDNF levels with hippocampal volumes in first psychotic episode drug-naive schizophrenic patients
- (2011) E.N. Rizos et al. SCHIZOPHRENIA RESEARCH
- Brain-derived neurotrophic factor levels in schizophrenia: a systematic review with meta-analysis
- (2010) M J Green et al. MOLECULAR PSYCHIATRY
- An inverse relationship between cortisol and BDNF levels in schizophrenia: Data from human postmortem and animal studies
- (2010) George Issa et al. NEUROBIOLOGY OF DISEASE
- The study of BDNF Val66Met polymorphism in Chinese schizophrenic patients
- (2010) Dong Hao Zhou et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- The effect of depression, BDNF gene val66met polymorphism and gender on serum BDNF levels
- (2009) Erol Ozan et al. BRAIN RESEARCH BULLETIN
- Age at onset and cognition in schizophrenia: meta-analysis
- (2009) T. K. Rajji et al. BRITISH JOURNAL OF PSYCHIATRY
- The Met allele of the BDNF Val66Met polymorphism is associated with increased BDNF serum concentrations
- (2009) U E Lang et al. MOLECULAR PSYCHIATRY
- Decreased levels of serum brain-derived neurotrophic factor in drug-naïve first-episode schizophrenia: relationship to clinical phenotypes
- (2009) Da Chun Chen et al. PSYCHOPHARMACOLOGY
- Symptoms as mediators of the relationship between neurocognition and functional outcome in schizophrenia: A meta-analysis
- (2009) Joseph Ventura et al. SCHIZOPHRENIA RESEARCH
- Clinical characteristics influencing age at onset in psychotic disorders
- (2008) Dost Öngür et al. COMPREHENSIVE PSYCHIATRY
- Once-weekly d-cycloserine effects on negative symptoms and cognition in schizophrenia: An exploratory study
- (2008) D GOFF et al. SCHIZOPHRENIA RESEARCH
- BDNF Val66Met variant and age of onset in schizophrenia
- (2007) Helen M. Chao et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS
- Whole blood BDNF levels in healthy twins discordant for affective disorder: Association to life events and neuroticism
- (2007) Viktorija Trajkovska et al. JOURNAL OF AFFECTIVE DISORDERS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search